In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
Parkinson’s disease (PD), multiple system atrophy (MSA) and Dementia with Lewy bodies (DLB) represent pathologically similar, progressive neurodegenerative disorders characterized by the pathological aggregation of the neuronal protein α-synuclein. PD and DLB are characterized by the abnormal accumu...
Main Authors: | Maria Fouka, Panagiota Mavroeidi, Grigoria Tsaka, Maria Xilouri |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2020.559791/full |
Similar Items
-
Neurons and Glia Interplay in α-Synucleinopathies
by: Panagiota Mavroeidi, et al.
Published: (2021-05-01) -
Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
by: Martin Kallab, et al.
Published: (2018-07-01) -
Exosomes in Alpha-Synucleinopathies: Propagators of Pathology or Potential Candidates for Nanotherapeutics?
by: Panagiota Mavroeidi, et al.
Published: (2022-07-01) -
Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies
by: Juan Huang, et al.
Published: (2024-03-01) -
O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson’s disease
by: Willayat Y. Wani, et al.
Published: (2017-07-01)